March 28, 2024
“…SoFi stock: Down 26% this year and 73% from its high… SoFi’s revenue increased 35% year over year to $615 million in the fourth quarter, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) increased 159% to $181 million.… Continue Reading…
March 12, 2024
“…Given its massive potential to change how people store and transfer wealth, it’s not surprising that Bitcoin (CRYPTO: BTC) is a favorite asset for Wood and her analyst team. The world’s most valuable cryptocurrency has made for a fantastic investment, soaring 1,540% in… Continue Reading…
March 6, 2024
“Taxpayer-funded ‘guaranteed income’ programs that hand struggling families up to $36,000 with no strings attached are being rolled out across the country, DailyMail.com analysis reveals. The schemes, whose total value exceeds $125 million, have surged in popularity since the pandemic as… Continue Reading…
March 4, 2024
“…the retailer warned of another year of softer sales and said it would lay off workers and cut other costs across the business. CEO Corie Barry offered few specifics, but said the company has to make sure its workforce and… Continue Reading…
February 26, 2024
“Share prices of Nvidia (NASDAQ: NVDA) and CrowdStrike (NASDAQ: CRWD) soared more than 1,000% and 400%, respectively, over the last four years. Those monster gains make the companies stock-split candidates in 2024, but both are worthwhile investments whether or not those splits happen… Grand View Research… Continue Reading…
February 22, 2024
“Capital One Financial is set to acquire Discover Financial Services in a $35.3 billion all-stock deal. Under the agreement, Discover shareholders would receive 1.0192 Capital One shares for each Discover share or about a 26% premium from Discover’s Friday closing price of $110.49. The… Continue Reading…
February 22, 2024
“Walmart has agreed to buy TV maker Vizio, the companies announced Tuesday, as the largest U.S. retailer grows its high-profit ad business. Walmart will acquire Vizio for $2.3 billion, or $11.50 per share, in cash. The big-box retailer announced the acquisition as it reported… Continue Reading…
February 20, 2024
“Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion, gaining access to an experimental liver disease treatment with blockbuster potential as the U.S. drugmaker looks beyond its older HIV drugs for growth. Shares of the Newark, California-based drug developer jumped 24.6%… Continue Reading…
February 2, 2024
“…Investment research firm Fundstrat’s Tom Lee predicts that the S&P 500 index will jump as much as 30% this year from 2023 levels. The Nasdaq-100 index is also seeing forecasts of robust gains in 2024 following the impressive 54% jump it clocked in 2023.… Continue Reading…
Recent Comments